Regenerative therapy
Does Young-Donor Plasma Infusions work?
Young blood, Ambrosia-style
Debunked / avoid
Debunked and FDA-warned. No proven benefit, real risk.
What it is
Infusing plasma from young donors into older people for “rejuvenation” — a commercial spin-off of mouse parabiosis experiments.
The evidence
None credible in humans. Ambrosia sold infusions for ~$8,000–$12,000 and ran a pay-to-enroll “trial” that never published efficacy.
The honest reality
In Feb 2019 the FDA cautioned consumers that young-donor plasma for aging/dementia has “no proven clinical benefit” and carries infectious, allergic, and cardiovascular risks. Some clinics still offer it — avoid.
Regulatory status
FDA consumer caution stands (2019). Not an approved anti-aging therapy anywhere.
Frequently asked questions
Does Young-Donor Plasma Infusions work for anti-aging?
Debunked and FDA-warned. No proven benefit, real risk. None credible in humans. Ambrosia sold infusions for ~$8,000–$12,000 and ran a pay-to-enroll “trial” that never published efficacy.
Is Young-Donor Plasma Infusions FDA-approved or safe?
FDA consumer caution stands (2019). Not an approved anti-aging therapy anywhere. In Feb 2019 the FDA cautioned consumers that young-donor plasma for aging/dementia has “no proven clinical benefit” and carries infectious, allergic, and cardiovascular risks. Some clinics still offer it — avoid.
Should I try Young-Donor Plasma Infusions?
Jevity grades Young-Donor Plasma Infusions as "Debunked / avoid". In Feb 2019 the FDA cautioned consumers that young-donor plasma for aging/dementia has “no proven clinical benefit” and carries infectious, allergic, and cardiovascular risks. Some clinics still offer it — avoid. Any decision belongs with a licensed clinician — this is educational information, not medical advice.
Sources
Educational information only — not medical advice, a diagnosis, or a recommendation to use any substance or therapy. Regulatory status changes; verify current rules and any personal decision with a licensed clinician. Jevity is operated by Upcapital Global FZCO, Dubai, UAE.